The ongoing supply issues surrounding pancreatic enzyme replacement therapy have progressed. These intermittent supply issues mean some people are running out of PERT, or experiencing difficulties or delays in accessing PERT. Therefore, there is a need for clinical and symptom management advice that is different to normal clinical practice.
The BDA is concerned about supply issues caused by shortages in Nutrition Borderline Substances (NBS), used to manage medical conditions and enteral feeding ancillaries as a result of global supply chain challenges, being felt across all four nations of the UK.
The BDA believes that nobody should live in food poverty and that UK Government and local authorities must take urgent action to lift people out of food poverty and prevent others from falling into food poverty. This should include enshrining a “Right to Food” in UK law.
This position statement aims to support UK dietitians in clinical practice (in both paediatric and adult settings) to ensure tube-fed individuals receive effective, evidence-based, equitable and quality care.
Low-carbohydrate diets (i.e. defined as diets containing between 50g and 130g carbohydrate) can be effective in managing weight, improving glycaemic control and cardiovascular risk in people with Type 2 diabetes in the short term
Dietitians have the expertise both at an individual patient and strategic level to identify, assess, care plan, treat, monitor and review individuals to achieve patient-centred outcomes, and train others to prevent and treat malnutrition.
The BDA supports and welcomes the government’s current childhood obesity strategy, published in August 2016. However, the association strongly believes that additional actions are needed to reduce the unacceptably high prevalence of childhood obesity in the UK.
The BDA strongly supports breastfeeding. We recognise that breastfeeding is the optimum form of nutrition for babies and that breastfeeding protects the health of babies and their mothers.
